Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6,678 | 6,604 | 6,163 | 6,694 | 7,051 | 7,073 | 6,730 | 6,957 | 7,589 | 7,074 | 6,541 | 7,119 | |
| COGS | 2,313 | 2,220 | 2,050 | 2,193 | 2,283 | 2,264 | 2,189 | 2,171 | 2,498 | 2,632 | 2,249 | 2,667 |
| Gross profit | 4,365 | 4,384 | 4,113 | 4,501 | 4,768 | 4,809 | 4,541 | 4,787 | 5,092 | 4,442 | 4,293 | 4,452 |
| 2,632 | 2,637 | 2,800 | 2,786 | 2,883 | 2,829 | 3,014 | 3,009 | 3,197 | 3,188 | 3,345 | 3,261 | |
| 1,733 | 1,747 | 1,313 | 1,715 | 1,885 | 1,980 | 1,527 | 1,778 | 1,895 | 1,255 | 947 | 1,191 | |
| OPM % | 26% | 26.5% | 21.3% | 25.6% | 26.7% | 28% | 22.7% | 25.6% | 25% | 17.7% | 14.5% | 16.7% |
| Depreciation | 290 | 233 | 288 | 247 | 272 | 280 | 309 | 253 | 297 | 278 | 383 | 304 |
| Interest | 26 | 30 | 18 | 18 | 15 | 15 | 14 | 14 | 13 | 14 | 13 | 17 |
| 176 | -10 | 249 | 160 | 191 | 222 | 289 | 259 | 269 | -70 | 148 | 211 | |
| Profit before tax | 1,594 | 1,474 | 1,257 | 1,611 | 1,788 | 1,907 | 1,493 | 1,769 | 1,854 | 893 | 699 | 1,080 |
| Tax | 438 | 405 | 325 | 435 | 483 | 332 | 279 | 478 | 500 | 219 | 157 | 295 |
| Tax % | 27.5% | 27.5% | 25.9% | 27% | 27% | 17.4% | 18.7% | 27% | 27% | 24.5% | 22.4% | 27.3% |
| 1,155 | 1,068 | 932 | 1,175 | 1,305 | 1,575 | 1,214 | 1,292 | 1,353 | 674 | 543 | 786 | |
| PAT margin % | 17.3% | 16.2% | 15.1% | 17.6% | 18.5% | 22.3% | 18% | 18.6% | 17.8% | 9.5% | 8.3% | 11% |
| EPS (₹) | 14 | 13.1 | 11.6 | 14.6 | 16.1 | 19.5 | 15.1 | 16.1 | 16.7 | 8.4 | 6.9 | 9.8 |
| Results filing | — | — | — | — | — | — | Results filing for Mar 2025 | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +14.6% | +13.7% | +7.4% | +5.8% | +5.6% | +7.1% | +9.2% | +3.9% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Dec 2025 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Pharmaceuticals | 6,746.4 | 1,122.26 | 0 | 0 |
| New ventures | 381.48 | 60.79 | 0 | 0 |
₹ crore by quarter
| +7.6% |
| +0% |
| -2.8% |
| +2.3% |
| PAT YoY % | +44.9% | +32.3% | +78.7% | +17.8% | +13% | +47.4% | +30.3% | +9.9% | +3.7% | -57.2% | -55.3% | -39.2% |